Stock listing

ITH0 Stock Price, News, Filings & Events — Nektar Therapeutics

Selected listing: ITH0 · TRADEGATE · EUR · DE

Nektar Therapeutics (ITH0:TRADEGATE) is a biopharmaceutical company focused on discovering and developing innovative therapies for patients with serious diseases. The company is actively engaged in advancing its pipeline of drug candidates and has recently made headlines with updates on clinical trials and partnerships. Investors can find the latest news, regulatory filings, and upcoming events related to Nektar Therapeutics on this page, providing valuable insights into its market position and strategic direction. The current market context highlights the growing interest in biopharmaceutical innovations, which may impact Nektar's future performance.

ITH0:TRADEGATEEURDEUpdated July 24, 2026
Nektar Therapeutics logo
Ticker
ITH0:TRADEGATE
Asset type
Stock
Market cap
$2.39B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
TRADEGATE
Currency
EUR

Nektar Therapeutics ITH0:TRADEGATE stock context

Nektar Therapeutics (ITH0:TRADEGATE) is a biopharmaceutical company focused on discovering and developing innovative therapies for patients with serious diseases. The company is actively engaged in advancing its pipeline of drug candidates and has recently made headlines with updates on clinical trials and partnerships. Investors can find the latest news, regulatory filings, and upcoming events related to Nektar Therapeutics on this page, providing valuable insights into its market position and strategic direction. The current market context highlights the growing interest in biopharmaceutical innovations, which may impact Nektar's future performance.

Research Nektar Therapeutics

Alternate listings